Logo

MWG Biotech Buys Another 454 Sequencer

Apr 15, 2008
NEW YORK (GenomeWeb News) – The German sequencing services company MWG Biotech has purchased a Genome Sequencer FLX system from 454 Life Sciences of the Roche Group, 454 said today.
 
This is MWG Biotech’s second GS FLX purchase. The Branford, Conn.-based Roche subsidiary said the system will allow MWG to improve the quality and enhance the speed of its sequencing services.
 
The GS FLX is used for de novo sequencing and re-sequencing of genomes, metagenomics, RNA analysis, and targeted sequencing of specific DNA regions, 454 said.
 
MWG Biotech bought its first GS FLX in July of last year.
 
 

Breaking News
The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.